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Abstract
Myogenesis, the formation of muscle ﬁbers, is a complex process. Pigs have been selected for eﬃcient muscle
growth for the past decades making them interesting to study myogenesis. We studied expression proﬁles of genes
known to aﬀect myogenesis, muscle structural proteins, and energy metabolism in prenatal pigs from 14 to
91 days of gestation. Primary and secondary muscle ﬁber formation takes place during days 30–60 and 54–90 of
gestation, respectively. Diﬀerential expression and expression levels of the genes were studied using microarray
technology. Gene activation and repression proﬁles were studied counting the number of spots with detectable
signal. The number of spots for muscle tissue structural protein genes showing upregulated expression increased
constantly from day 14 until day 91of gestation indicating continued activation of genes during this period. The
mRNA expression level of the genes showed a peak around day 35 of gestation. The expression levels of genes
aﬀecting myogenic diﬀerentiation (stimulating and inhibiting) showed a peak at day 35 of gestation. The number
of spots for diﬀerentiation-stimulating genes showing diﬀerential expression reaches a ﬁrst peak around day 35 of
gestation and a nadir at day 49 of gestation while the number of spots for diﬀerentiation-inhibiting genes reaches
a nadir at day 35 of gestation. Myogenic diﬀerentiation seems less a matter of the expression level of genes
aﬀecting diﬀerentiation, but depends on the balance between the number of signiﬁcantly activated genes for
stimulating and inhibiting diﬀerentiation. Genes stimulating myoblast proliferation showed a small peak
expression prior to day 35 of gestation indicating myoblast proliferation before diﬀerentiation. The number of
spots and the expression levels of genes for glycolysis and ATP-metabolism are at a nadir around days 35 and
49–63 of gestation suggesting that the energy metabolism is low during fusion of myoblasts into multinucleated
muscle ﬁbers.
Introduction
Mammalian myogenesis, the formation of new multi-
nucleated muscle ﬁbers from mononucleated precursor
cells called myoblasts, is an exclusive prenatal process
determining muscle characteristics such as ﬁber num-
bers, which may be related to muscle strength and
function (Rehfeldt et al., 2000). Muscle ﬁber formation
takes place in two waves, the primary and secondary
muscle ﬁber formation (Wigmore and Evans, 2002).
Each wave consists of proliferation of myoblasts and
fusion to form new muscle ﬁbers. While primary
muscle ﬁbers form de novo, secondary myoﬁbers form
using the primary ﬁbers as a template.
Improving growth rate and muscularity has been the
primary focus during the past decades in pig breeding
(Merks, 2000). This makes pigs a good animal model to
study myogenesis. Furthermore, the two waves of mus-
cle ﬁber formation have relatively long periods of time
in the pig, i.e. approximately day 30–60, and day 54–90
of gestation (Wigmore and Stickland, 1983). These long
periods – relative to gestation time in laboratory ani-
mals – enable the study of myogenesis in detail.
Myogenesis is under complex genetic regulation.
The Muscle Regulatory Factors (MRF) gene family
are transcription factors activating muscle-speciﬁc
genes during diﬀerent stages of myogenesis (Olson,
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1990; Weintraub et al., 1991). Myf-5 and MyoD regu-
late proliferation of myoblasts, myogenin regulates ter-
minal diﬀerentiation, and MRF4 is mainly involved in
maintenance of muscle tissue (Olson, 1990; Weintraub
et al., 1991). Genetic inﬂuence of the MRF gene fam-
ily on porcine muscle development has been shown be-
fore. Genetic variation in porcine myogenin was
related to muscle and general body growth (Soumillion
et al., 1997; te Pas et al., 1999a ) while myf-5 did not
show such a relationship (te Pas et al., 1999b ). Fur-
thermore, postnatal expression levels of myf-5, MyoD,
and myogenin were related to growth rate (te Pas
et al., 2000). (See for a review of the myogenesis in
livestock te Pas and Soumillion, 2001).
The expression of the MRF genes is under tight
temporal and spatial regulation, and numerous factors
aﬀecting MRF expression levels are known. A net-
work of genes aﬀects the expression patterns of the
MRF genes (Olson, 1993; Rawls and Olson, 1997;
Capdevila and Johnson, 2000; Dobosy and Selker,
2001; Kitzmann and Fernandez, 2001; Lee et al., 2001;
Zhu et al., 2001). By doing so they aﬀect muscle and
body growth potential. Using microarray technology
we studied the porcine expression of genes known to
aﬀect myogenesis in laboratory animals and in vitro
model systems. Microarray technology can simulta-
neously measure the diﬀerential expression of a large
number of genes in a given tissue and may identify the
genes responsible for diﬀerent phenotypes. The aims of
this study were (1) to describe speciﬁc myogenesis-re-
lated transcriptome proﬁles in pigs during prenatal
muscle development and (2) to relate these proﬁles to
biological function.
Materials and methods
Animals and collection of tissues
Embryos and fetuses of Duroc pigs were collected at
14, 21, 35, 49, 63, 77, and 91 days of gestation. The
sows were slaughtered at a commercial slaughterhouse
and the uterus containing the litter was collected
immediately after bleeding the animal. Fourteen-day
embryos were too small to collect individually. There-
fore, each uterus horn was ﬂushed with phosphate buf-
fered saline (PBS, pH7.5). Thus, results obtained with
14 days embryos are pooled embryos of one uterus
horn. Although 21-day embryos were collected individ-
ually, no muscle tissue was observed and whole em-
bryos were stored. In 35-day embryos a white colored
region where longissimus muscle formation was taking
place was observed. This region was excised and
stored. However, since the muscle itself was not visible
yet, the stored tissue may contain some skin and prob-
ably other tissues such as adipose tissue as well. The
longissimus muscle tissues from fetuses aging 49–
91 days of gestation were collected. All isolates were
snap frozen in liquid nitrogen and stored at )80C
until use.
Microarray construction
The microarray contained genes with known eﬀects on
myogenesis, energy metabolism, and muscle tissue
structural genes derived from a literature study (for
references and additional information about the
genes and the microarray see Table 1 of the additional
Table 1. Primers (A) and probes (B) for real time PCR
A
Gene Primers EMBL Location (nt)
GAPDH Forward: GGCTCTCCAGAACATCATCC AF017079 938–957
Reverse: CCCAGCATCAAAGGTAGAAGA 1229–1209
Col3A1 Forward: GCCATCCAGGACAACCAG AU059332 26–43
Reverse: ATCGGGACTAATGAGGCTTTC 243–223
EPO-receptor Forward: GAACCAGCCGCAGATGATG AF274305 1198–1216
Reverse: CCAGAGCAGATGAGCAGAAGG 1393–1373
TGF-beta2 Forward: CAACCGGCGGAAGAAG X70142 123–138
Reverse: CGTTTTGCCGATGTAGTAGAG 426–406
Beta-catenin Forward: GACGCTGCTCATCCCAC AB046171 543–559
Reverse: CAGCGAGCCGTTTCTACA 838–821
B
Gene Probe-name EMBL Location (nt)
GAPDH FL: CCATGCCAGTGAGCTTCCCG AF017079 1029–1009
LC640: GAGCTCAGGGATGACCTTGCCC 1007–986
Col3A1 FL: GCTTTTTCACCTCCAACACCAGCG AU059332 125–102
LC640: GGCAGCAGCCCCACCACC 99–82
EPO-receptor FL: CACAGCCTGGTGGTGATTTGGAC AF274305 1319–1341
LC640: GGCGGCCATGGATGAAGCC 1343–1362
TGF-beta2 FL: TAAACCCAGAAGCTTCTGCTTCCCC X70142 344–368
LC640: GCTGCGTGTCCCAGGATTTAGAACC 371–395
Beta-catenin FL: GCTTCCAGACATGCCATCATGCG AB046171 747–769
LC640: CTCCTCAGATGGTGTCTGCAATTGTACGT 772–800
The ﬂuorescein group is attached to the 3¢-end of the FL probe, the red ﬂuorochrome LC640 is attached to the 5¢-end of the LC640 probe and the
3¢-end contains a phosphate group.
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information). Several of the genes were members of
closely related gene families. In such cases a number of
family members were also placed on the microarray.
These genes were cloned from pig mRNA isolated
from the embryos/fetuses. RNA from unrelated em-
bryos/fetuses, two of each age, were isolated, reverse
transcribed, and the cDNAs were pooled. Gene-spe-
ciﬁc primers (see Table 1, additional information) were
constructed and used to amplify a fragment on this
cDNA pool. The fragments were cloned and if the
PCR product did not exactly match the expected
length were sequenced to verify the product (see also
additional information, Table 1). Furthermore, 309 se-
quenced clones of an adult-pig-muscle-speciﬁc cDNA
library (Davoli et al., 2001) including many muscle
structural and energy metabolism-related genes were
placed on the microarray. In total the microarray con-
tained 557 genes with known identity and function.
The clones were ampliﬁed in four 50-ll PCR reac-
tions to obtain a total 200 ll total volume PCR product
for each clone. These four diﬀerent PCR products for
each clone were collected in the same tube of a 96 well
microtiter plate and puriﬁed according to the Sephadex
protocol. The puriﬁed products were precipitated using
the absolute ethanol–Sodium acetate–70% ethanol pro-
tocol and resuspended in 20 ll spotting buﬀer (1 M
phosphate buﬀer pH 5.8, 50% DMSO). After that the
length, the quantity, and the quality of each fragment
was checked on a 1% agarose gel. Two nano liter of the
products were spotted on glass slides in duplicate.
Microarray hybridization and analysis
RNA from the six embryos per prenatal age was iso-
lated using the Trizol–Phenol method (Life Technolo-
gies, Breda, The Netherlands). Two microgram of
RNA for each stage was labeled with Cy3 or Cy5
using the TSA labeling and ampliﬁcation kit protocol
(Perkin Elmer Life Sciences, Inc., Langen, Germany).
Hybridizations compared always two prenatal stages
of follow up ages of gestation, i.e. 14–21 days, 21–
35 days, etc. Hybridizations were performed in dupli-
cate and in duplicate dye swap. Hybridization was
done for 16 h at 65C. After hybridization the slides
were rinsed according to the stringency washing proto-
col recommended by the manufacturer.
Microarrays were scanned using the GeneTac2000
scanner (Genomics Solutions, USA) for 180 s. Each
microarray was analyzed independently using the fol-
lowing steps: (1) Normalization of raw scanning data,
which included (a) background correction – the back-
ground signal was determined using blank spots, and
spots with water but no PCR product, (b) normaliza-
tion (i) using all spots, and (ii) per patch; all intensity
dependent using a LOWESS (locally weighted scatter-
plot smoothing, Cleveland, 1974; Park et al., 2003) ﬁt;
After this the normalized spots are represented by
their M and A values following the procedure as de-
scribed by Pool et al. (2003):
M = log2 (Cy5/Cy3), Thus the M-value is the ratio
between the expression of the gene in the Cy5 and Cy3
labeled sample indicating the diﬀerential expression be-
tween the Cy5 and Cy3 labeled RNA samples – thus,
a positive M-value indicates that the expression of the
Cy5 labeled RNA is higher than the expression of the
Cy3 labeled RNA, and a negative M-value indicated
the reverse situation;
A = (log2 [Cy5 · Cy3])/2, Thus the A-value indi-
cates a weighed mean expression level of the Cy5 and
Cy3 labeled RNA samples (Yang et al., 2002).
Additionally the signiﬁcance of the diﬀerence (M-va-
lue) is indicated by the P-value, two-sided tested on a
log–logistic distribution. (2) Next, normalized spots
with diﬀerence Cy3–Cy5 P > 0.05 and/or
)1.58 < M < 1.58 (log2 scale) were discarded leaving
only those genes with a diﬀerence in expression level
of 3· or more (normal scale) according to the protocol
of the manufacturer of the labeling kit (Perkin Elmer)
to eliminate false positive results. (3) The remaining
spots were analyzed for up or down regulation of
expression by comparing the expression levels in the
breeds using the M- and A-values using the Spotﬁre
pro 7 software (BioASP, Amsterdam, The Nether-
lands). (4) The gene activation and repression proﬁles
were studied by counting the number of spots (genes)
with a detectable signal. The results were also analyzed
for number of spots with diﬀerential expression to
investigate the overall eﬀect on biological groups (see
also next step). (5) Finally, the results were analyzed
with biological interpretation of data using available
data on the physiology of the genes, is described in the
Results section.
Real time PCR validation
To validate the results of the microarrays ﬁve genes of
step (4) of the normalization-analysis of the micro-
arrays (see above) were selected and analyzed with real
time PCR using the Lightcycler equipment (Roche
Diagnostics, Almere, The Netherlands). Genes were
chosen in each functional group. Because of the rele-
vance three genes were chosen in the myogenesis
aﬀecting group (EPO-receptor, b-catenin, and
TGFb2), one household gene in the energy metabolism
group (GAPDH) and a muscle structural gene (colla-
gen 3A1). Primers were designed on the cDNA se-
quence to amplify a 100–300 bp fragment and probes
containing a ﬂuorescein were designed according to
the rules set by the manufacturer (Table 1). All reac-
tions had an annealing temperature of 60C except
TGF-beta2 (55C) and a magnesium concentration of
3 mM except beta-catenin (5 mM). For real time PCR
each developmental age was represented by individual
RNA samples from the same six embryos or fetuses
used in the microarray experiments. Reverse transcrip-
tion and PCR were done on individual RNAs. A sec-
ond set of cDNA samples of diﬀerent embryos/fetuses
supplied by Dr K. Wimmers (University of Bonn,
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Germany) was used for independent veriﬁcation of the
results.
Normalization of RT-PCR usually uses structural
(e.g. beta-actin) or household genes (e.g. GAPDH),
several of which were included in the microarrays. The
results of the microarrays indicated that the expres-
sions of these genes were regulated during the investi-
gated prenatal period. Thus these genes were not
suitable for normalization (Radonic´ et al., 2004).
Therefore, we used the 18S rRNA expression as an
independent non-protein gene for normalization. The
18S rRNA expression showed no diﬀerential expres-
sion during the 35–91 days of gestation period, while
being low in embryos aged 14-days and 21-days. This
may relate to the diﬀerence of the isolated tissues.
Results
Microarray analysis
Prenatal age dependent development of expression pat-
tern
Based on known biological function genes were
grouped into three major groups: myogenesis
(n = 178), energy metabolism (n = 80), and muscle
structural (n = 48) genes. The ﬁrst two groups have
been sub-divided into pathway-speciﬁc subgroups (Ta-
ble 2). Some genes belong to more than one group.
Results were analyzed for (1) up/down regulation – i.e.
the ratio between the expression level in one age pre-
natal samples versus another age prenatal samples, (2)
for general expression level, and (3) for gene activa-
tion/repression proﬁles. Table 2 shows that most, but
not all genes that belong to a (sub) group show diﬀer-
ential expression, and that not all genes showing dif-
ferential expression do so at all prenatal ages.
Expression level proﬁle
The expression level of the genes was studied using the
A-values of spots. The proﬁles (Figure 1(a)) indicate
that the genes involved in muscle ﬁber formation, i.e.
diﬀerentiation-stimulating, diﬀerentiation-inhibiting,
and muscle ﬁber structural genes, show a peak expres-
sion around day 35. The proliferation-stimulating
groups of genes show lower peak levels. A detailed
analysis (Figure 1(b)) shows that proliferation-stimu-
lating genes show a much smaller peak at the same
time. Furthermore, expression of glycolysis metabolism
genes is at a nadir at the two period’s central in diﬀer-
entiation: around days 35 and 49–63. ATP metabolism
follows that proﬁle later in time while oxidative phos-
phorylation has less variable expression.
Gene activation and repression proﬁles
Activation and repression of gene expression are
important characteristics of prenatal development.
Therefore we studied these processes counting the
number of spots on the microarrays with detectable
expression levels, i.e. spots with expression levels above
background levels + SD of the background. M- and
A-values were calculated for these spots only. Next the
numbers of spots involved with diﬀerential expression
were analyzed. Figure 2(a) shows that the number of
spots of muscle ﬁber structural genes rapidly increases
from day 21 until day 49. While still spots indicate in-
creased expression of genes until day 91 the genes in-
duced early (day 21) show reduced expression from day
Table 2. Number of genes within each functional group and number of genes showing diﬀerential expression within each group and each
prenatal age
Biological functional pathway Day by day comparison
n n-list 14–21d 21–35d 35–49d 49–63d 63–77d 77–91d
Energy metabolism genes 80 74
Glycolysis 22 21 13 17 14 7 13 10
Oxidative Phosphorylation 17 17 5 14 10 4 7 7
ATP metabolism 18 17 15 15 9 7 4 6
Fatty acid metabolism 10 9 4 2 4 1 5 2
Miscellaneous* 9 9 3 5 6 3 4 2
Myogenesis genes 178 173
Diﬀerentiation-stimulating 48 48 15 18 21 16 18 20
Diﬀerentiation-inhibiting 44 44 20 20 24 13 13 11
Proliferation stimulating 42 40 16 19 18 9 14 11
Proliferation inhibiting 16 16 6 7 7 2 8 5
Migration 5 5 3 2 2 3 0 0
Structural genes 48 45
Myocyte structural genes 48 45 14 27 24 17 25 16
Early structural genes 8 8 6 6 2 4 4 4
Groups of genes involved in energy metabolism, myogenesis, and muscle tissue structure were created. Groups are divided in subgroups
indicating pathways. n: the total number of genes within on the microarray; n-list: the number of genes giving at least at one prenatal age
signiﬁcant diﬀerential expression.
* Containing genes such as for Creatine metabolism, being important for energy metabolism but not related to groups indicated above.
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49 onwards (Figure 2(a)). Analysis of groups of myo-
genesis involved genes (Figure 2(b)) indicate that the
number of genes showing diﬀerential expression in-
volved in stimulation of proliferation is relatively sta-
ble, showing a small decrease between days 35 and 63
of gestation, and a second small decrease towards the
end of gestation. Diﬀerentiation-stimulating gene num-
bers are reduced initially, but gene numbers rise to-
wards days 35 and days 63–77. The numbers of
diﬀerentiation-inhibiting genes showing diﬀerential
expression is reduced around day 35 and, to a lesser ex-
tend, around day 63. Changes in the number of diﬀeren-
tially expressed energy metabolism genes (Figure 2(c))
indicate that the number of genes involved in glycolysis
and ATP metabolism increase between days 14 and 21
and are reduced at day 35. After this the number of dif-
ferentially expressed glycolysis genes is increased until
day 49, is reduced again at day 63, and increases after-
wards, while the number of genes involved in ATP
metabolism is relatively stable. The number of genes in-
volved in oxidative phosphorylation showing diﬀerential
expression seems to be reduced until day 49 of gestation
and remains stable afterwards.
Real time PCR validation of microarray results
Real time PCR validation of microarrays was per-
formed with ﬁve genes diﬀerentially expressed and
chosen such that all major groups of genes analyzed
are represented (Figure 3). Col 3A1 represents the
(early) muscle structural genes, GAPDH represents en-
ergy metabolism genes, especially glycolysis metabo-
lism, EPO-receptor, beta-catenin, and TGF-beta2
represent myogenesis genes, diﬀerentiation-inhibiting
and proliferation-stimulating, proliferation-stimulating,
and diﬀerentiation-inhibiting, respectively. The real
time PCR analyses were done on the individual RNA
isolates (not pools as used for the microarrays). The
standard error (SE) was variable with the prenatal age.
The SE may be up to 30% of the mean at 14 days of
age (mainly because the RT-PCR failed on a few sam-
ples) while at older ages the SE was 1–5% of the mean
(data not shown).
The Col3A1 mRNA expression is barely detectable
at 14 days of age, is upregulated at 21 days of age
reaches a maximum at 35 days. Col3A1 is down regu-
lated after 35 days of age, with a small second peak in
the expression around days 63–77 of age. This corre-
lates with the myogenic diﬀerentiation representing
Fig. 2. Gene activation and repression proﬁles as measured by the
number of spots with detectable signal of each prenatal developmen-
tal age. (a) Structural genes, black line: structural genes; broken line:
early structural genes, (b) myogenesis aﬀecting genes, black line: dif-
ferentiation-stimulating genes; gray line: diﬀerentiation-inhibiting
genes; broken line: proliferation-stimulating genes; and (C) Energy
metabolism genes, black line glycolysis genes; gray line: fatty acid
metabolism genes; broken line: ATP-metabolism genes; dotted line:
oxidative phosphorylation genes.
Fig. 1. Proﬁle of mean A-values per group of genes indicating abso-
lute expression levels per group on each developmental age.
(a) Black line: diﬀerentiation-stimulating genes; gray line: diﬀerentia-
tion-inhibiting genes; broken line: Structural genes (b) Black line:
glycolysis genes; gray line: proliferation-stimulating genes; broken
line: ATP-metabolism; dotted line: oxidative phosphorylation. Please
note the diﬀerent Y-axis scale between ﬁgures (a) and (b).
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genes indicating peak expression at 21 days of age
(EPO-receptor and TGF-beta2) or 21–35 days of age
(beta-catenin). Meanwhile, the GAPDH gene repre-
senting energy metabolism is at a nadir around day 35
of gestation. After the nadir its expression level in-
creases, but reaching a second smaller nadir at day 77
of gestation. These results were conﬁrmed with inde-
pendently isolated prenatal samples of diﬀerent ani-
mals including diﬀerent litters (data not shown).
Discussion
Microarray analysis of prenatal muscle tissue formation
Microarray analysis is a very powerful tool allowing
the analysis of complete transcriptomes of tissues. The
combined expression analysis of all or many genes
from pathways may provide insight into the combined
regulation of processes – such as the formation of tis-
sues – or pathways and may help to discover how var-
ious pathways are connected. If many genes that
regulate a process are known this process can be stud-
ied in detail by producing specialized dedicated micro-
arrays containing especially those genes.
However, the enormous amount of data generated
by microarray analysis requires stringent statistical
evaluation to avoid the generation of many false posi-
tive results. Also the labeling and hybridization meth-
ods used have limitations. In our study we therefore
have ﬁrst eliminated all data with P > 0.05, and
thereafter all data with M-values indicating a diﬀeren-
tial expression smaller than three times – as recom-
mended to eliminate false positive results. As a
consequence many data are regarded non-signiﬁcant,
among them will be false negative data. Although on
the individual gene level the diﬀerences are big (many
genes were not included in the second analysis) the
conclusions for the functional groups are similar.
Group variability was reduced in the second analysis
compared to the ﬁrst analysis, probably caused by
false positives. Finally, these false negative results of
the microarray analysis may result in small diﬀerences
with analysis by other methods such as real time PCR,
which are able to indicate smaller diﬀerences too.
Early embryo sampling
Very young embryos are small. It is impossible to iso-
late 14 day old individual pig embryos on a large
Fig. 3. Real time PCR of ﬁve genes representing the major functional groups. Erythropoietin (EPO)-receptor (a), beta-catenin (b), and
Transforming Growth Factor (TGF)-beta 2 (c) represent myogenic genes, diﬀerentiation-inhibiting and proliferation-stimulating, prolifera-
tion-stimulating, and diﬀerentiation-inhibiting, respectively.Collagen (Col) 3A1 (d) represents the (early) muscle structural genes, and glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) (e) represents energy metabolism genes, especially glycolysis metabolism. The data were
normalized against the 18S rRNA expression.
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enough scale fast enough to avoid RNA degradation
and/or change of RNA expression of genes. Above
that, the amount of RNA isolated from these embryos
would be far too small to be used in microarray exper-
iments. Therefore we have collected 14-day embryos
ﬂushing an entire uterus horn. As a consequence these
samples contain both embryonic and extra-embryonic
prenatal cells. For 21-days old embryo samples con-
tain individual whole embryos. These embryos are too
small to isolate and use individual tissues, and muscle
tissue is not visible in these young embryos. Therefore,
the results obtained with these young embryos may be
partly inﬂuenced by other tissues. This may be particu-
larly the case for energy metabolism genes. Likewise
some signal from non-muscle speciﬁc transcripts of
myogenesis and structural genes cannot be excluded in
these young embryos. On the other hand, at best mus-
cle precursor cells will be present in these embryos,
mainly in somites. We have considered this by includ-
ing eight genes known to aﬀect somite development
into the group of myogenesis aﬀecting genes (see Table
1, additional information). None of these genes show
signiﬁcant diﬀerential expression at any developmental
stage (data not shown). Therefore, we consider the
data obtained with these samples reliable. Finally, to a
minor extend also the samples of 35-day old embryos
diﬀer. These samples contain mainly the area where
muscle formation is taking place (but no muscle tissue
is visible yet). Some adipocytes and skin tissue may be
in the samples. However, adipocytes constitute a part
of normal muscle tissue too. Nevertheless, it is good to
recognize that only from day 49 of gestation and on-
wards pure longissimus tissue is sampled and analyzed.
Prenatal muscle-speciﬁc expression proﬁle related to
myogenesis
Prenatal development is characterized by massive
changes at the cellular phenotypic and the gene expres-
sion levels during the formation of body tissues. Mus-
cle tissue is a major constituent of the body and
muscle ﬁbers are the major constituent of muscle tis-
sue. Therefore we studied the expression proﬁles of
genes known to be involved in muscle ﬁber formation
and muscle structural genes. Furthermore, diﬀerentia-
tion requires massive cell phenotype rebuilding which
include expression of muscle developmental stage and
phenotype-related proteins. In the case of muscle cells
this also includes fusion of myoblasts and restructur-
ing of the resulting multinuclear cell into a functional
muscle ﬁber. The energy metabolism should be suit-
able to supply the tissue with the required energy for
the processes including the protein speciﬁc synthesis of
each developmental step. Therefore, we included genes
representing glycolysis, oxidative phosphorylation, and
ATP metabolism in our microarray.
Our results indicate ﬁrstly that the changes in myo-
genesis related, muscle ﬁber structural, and energy
metabolism-related genes are more intense in the
period of primary muscle ﬁber formation than in the
period of secondary muscle ﬁber formation. We ob-
served that at the moment of muscle ﬁber formation
the expression of diﬀerentiation-stimulating genes, dif-
ferentiation-inhibiting genes and muscle ﬁber struc-
tural genes is increased.
When diﬀerentiation of muscle ﬁbers takes place
(i.e. day 35 of gestation for primary muscle ﬁber for-
mation) it is remarkable that the number of muscle
structural genes and muscle diﬀerentiating genes show-
ing diﬀerential expression remains largely unchanged
(Table 2) while the number of spots for these genes in-
creases (Figure 2). At the same time number of diﬀer-
entiation-inhibiting genes showing diﬀerential
expression is similarly unchanged (Table 2) while the
number of spots is reduced (Figure 2). All three
groups of genes show a high expression level (A-value)
at the moment of diﬀerentiation (Figure 1). Each gene
is represented on each time point by a maximum of
eight spots (duplicate spots per microarray, four
microarray hybridizations per time point). Only spots
indicating a reliable signiﬁcant diﬀerential expression
are counted. The number of spots per gene is thus a
measure for the repeatability of the diﬀerence of the
expression levels, which may indicate the reliability of
the measurements (the more signiﬁcant spots, the higher
the repeatability of the result, the more reliable the
data). Alternatively, when the number of signiﬁcant
spots per gene decreases this may just indicate a lesser
degree of diﬀerence in expression inducing false nega-
tive results. The interpretation of the above mentioned
changes in number of spots per gene for the diﬀerenti-
ation-stimulating and the muscle structural genes may
indicate increased activity of these genes while the
opposite is true for the myogenesis inhibiting group of
genes. Thus, diﬀerentiation seems to be the result of a
balance between the number of (spots) genes stimulat-
ing and inhibiting diﬀerentiation rather than the
expression level of the expressed genes themselves. If
the expression level of a higher number of (spots)
genes stimulating diﬀerentiation increases and the
number of genes inhibiting diﬀerentiation decreases –
despite a higher expression level of the remaining
genes – diﬀerentiation takes place. Dedieu et al. (2002)
proposed that initiation of the fusion step – which is
an essential component of diﬀerentiation, only proceed
when the MRF genes reach a threshold. Our results
indicate that this threshold may not only depend on
the expression levels of the MRF genes but requires
the balance of many diﬀerentiation-stimulating and
-inhibiting genes.
As formed myoﬁbers require speciﬁc structural
genes it is not surprising to note that these genes also
show increased expression. Within the muscle ﬁber
structural genes there seem to be two components:
Those that are expressed early (from day 21 onwards)
and those that are expressed later (after day 35) with
the ﬁrst showing decreased expression after day 49
(but with a small peak during secondary muscle ﬁber
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formation) and the second group remaining highly ex-
pressed, at least until day 91 when muscle ﬁber forma-
tion is completed.
Pigs have a history of selection for increased muscu-
larity. Our data indicate that day 35 of gestation, and
to a lesser extent also the period around day 63 of ges-
tation are major moments in myogenesis. It would be
interesting in future studies to investigate the expres-
sion proﬁles at these moments of prenatal develop-
ment in more detail. It can be assumed that many
processes regulating postnatal muscularity and muscle
failure can be explained from such studies.
Myogenesis is regulated by the MRF genes, a family
of muscle ﬁber-speciﬁc transcription factors that regu-
late developmental-speciﬁc gene expression (Olson,
1990, Weintraub et al., 1991), which has been shown
to be active in pigs too (for a review see te Pas and
Soumillion, 2001). Many proteins have been shown to
aﬀect myogenesis via the MRF genes (for many refer-
ences see Table 1, additional information). However,
in our microarray analysis where many of the above
mentioned genes showed indeed diﬀerential expression
we did not ﬁnd reliable (i.e. repeatable signiﬁcant
according to the speciﬁcations of the labeling kit) dif-
ferential expression of the MRF genes. This may be
caused by the analysis of the microarray as discussed
above taking only diﬀerential expression greater than
three times as reliable. More subtle changes in the
expression are regarded as not signiﬁcant. However,
also in our analysis taking all data with P < 0.05 into
account the MRF genes showed only marginally dif-
ferential expression proﬁles with sometimes conﬂicting
data. Thus, we consider the expressional changes of
the MRF genes as marginal or not important. This
does not imply that the MRF genes are not important
in pig muscle development, but mRNA expressional
changes related to primary of secondary muscle ﬁber
formation are not observed as a major eﬀect in our
pigs. Alternatively, several proteins regulate MRF
function by binding to the MRF proteins either acti-
vating or inhibiting MRF function. Such eﬀects will
not be measured with microarray analysis. Thus, the
activity of the MRF proteins may be regulated with-
out (big) alterations of mRNA expression.
It has been shown in vitro that Insulin-like growth
factor (IGF)-I increases myogenin expression 60-fold
(Florini et al., 1991). While the IGF proteins are also
potent prenatal activators, it is mainly the IGF-II that
acts prenatal (Rappolee et al., 1992; Stylianopoulou
et al., 1988). However, neither IGF-I nor IGF-II, nor
the receptors were greatly diﬀerentially regulated.
Thus, in our experiment we may conclude that MRF
gene expression seems not regulated by the IGF sys-
tem. Alternatively, Coutinho et al. (1993) showed in a
quail selection experiment that increased numbers of
muscle ﬁbers were related to delayed expression of
MRF genes rather than upregulated expression. It
would be interesting to investigate the expression pro-
ﬁles of all myogenesis aﬀecting genes on selection-re-
lated timing of expression.
We have shown previously that the expression of the
MRF genes was upregulated in post-natal muscle tis-
sue due to selection for increased growth rate and
muscle growth (te Pas et al., 2000). Similar upregula-
tion may have occurred in the prenatal pig. Since
selection-related changes in prenatal expression proﬁles
are unknown we can only speculate on this point. Fu-
ture research should aim on this as it marks important
points in time in the development of body tissues.
Prenatal muscle-speciﬁc energy metabolism expression
proﬁle related to myogenesis
The results of the energy metabolism were unexpected.
Indeed, there seems to be a relationship with the mus-
cle ﬁber formation, but a negative relationship. As
muscle ﬁber formation takes place, expression of en-
ergy metabolism genes is low. Although we realize that
microarrays study the transcriptome of cells, which is
not necessarily equal to the proteome or the activity of
enzymes, it may indicate that diﬀerentiation takes
place during low energy status of the cells. Energy
content of satellite cell cultures has been related to
hypertrophy of muscle ﬁbers in vitro (Louis et al.,
2004). Adding creatine to satellite cell cultures in-
creases IGF-I level and expression of the four MRF
genes, although only myogenin was increased over
three-fold. The authors did not report changes to myo-
ﬁber numbers, so these results cannot be compared di-
rectly, but this is an additional indication for a
connection between the myogenesis pathway and the
energy metabolism pathways. Furthermore, two recent
publications showed regulation of genes involved in
energy metabolism during myogenesis. Riera et al.
(2003) showed down regulation of 6-phosphofructo-2-
kinase – a key enzyme in the control of glycolysis and
gluconeogenesis – by ubiquitin/proteasome proteolysis
during myogenic diﬀerentiation in C2C12 cells and
Chen et al. (2003) showed that BMP9 regulates both
phosphoenolpyruvate carboxykinase (PEPCK) – a key
enzyme in glycolysis – and Akt kinase – involved in
diﬀerentiated myotubes. These results, although frag-
mentary, point to a connection between energy metab-
olism and myogenic diﬀerentiation, as we have shown
on a much larger scale.
At present no good biological reasons for this ob-
served eﬀect can be given. It may be suggested that fu-
sion of cells requires low energy status, but our
understanding of the role of energy metabolism in
myogenesis remains poor.
Summarizing, we have shown that porcine myogene-
sis is associated with balanced coordinated regulation
of expression. This involves genes related to myogene-
sis (both positively and negatively regulating myogene-
sis), muscle structural genes, and energy metabolism
genes.
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